BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 18760341)

  • 1. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
    Kaur P; Kim K
    Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.
    Yu H; Kim K
    Int J Pharm; 2009 Aug; 378(1-2):73-9. PubMed ID: 19501141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of nimodipine in brain following intranasal administration in rats.
    Zhang QZ; Jiang XG; Wu CH
    Acta Pharmacol Sin; 2004 Apr; 25(4):522-7. PubMed ID: 15066224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats.
    Zhao Y; Yue P; Tao T; Chen QH
    Acta Pharmacol Sin; 2007 Feb; 28(2):273-8. PubMed ID: 17241531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and biodistribution of rizatriptan to blood and brain following different routes of administration in rats.
    Wang C; Quan LH; Guo Y; Liu CY; Liao YH
    Int J Pharm; 2007 Jun; 337(1-2):155-60. PubMed ID: 17267150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of baicalin-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration.
    Li N; Je YJ; Yang M; Jiang XH; Ma JH
    Pharmazie; 2011 May; 66(5):374-7. PubMed ID: 21699072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
    Ved PM; Kim K
    Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
    Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z
    Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats.
    Li F; Feng J; Cheng Q; Zhu W; Jin Y
    Int J Pharm; 2007 Jan; 328(2):161-7. PubMed ID: 17049426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic behavior of huperzine A in plasma and cerebrospinal fluid after intranasal administration in rats.
    Wang Q; Chen G
    Biopharm Drug Dispos; 2009 Dec; 30(9):551-5. PubMed ID: 19780094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
    Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
    Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huperzine A in rat plasma and CSF following intranasal administration.
    Yue P; Tao T; Zhao Y; Ren J; Chai X
    Int J Pharm; 2007 Jun; 337(1-2):127-32. PubMed ID: 17241758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of lorazepam-loaded microemulsions for intranasal delivery and its pharmacokinetics.
    Yao J; Hou L; Zhou JP; Zhang ZQ; Sun L
    Pharmazie; 2009 Oct; 64(10):642-7. PubMed ID: 19947165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the distribution of breviscapine in the brain by different administration routes].
    Shi SL; Xu LY; Wu JJ; Li CY; Ge WH; Dai WY
    Yao Xue Xue Bao; 2009 May; 44(5):515-8. PubMed ID: 19618729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
    Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
    Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct transport of VEGF from the nasal cavity to brain.
    Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
    Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain distribution of ribavirin after intranasal administration.
    Colombo G; Lorenzini L; Zironi E; Galligioni V; Sonvico F; Balducci AG; Pagliuca G; Giuliani A; Calzà L; Scagliarini A
    Antiviral Res; 2011 Dec; 92(3):408-14. PubMed ID: 22001322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain pharmacokinetics of tetramethylpyrazine after intranasal and intravenous administration in awake rats.
    Feng J; Li F; Zhao Y; Feng Y; Abe Y
    Int J Pharm; 2009 Jun; 375(1-2):55-60. PubMed ID: 19481691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.